Cullinan Shane, O'Mahony Denis, O'Sullivan David, Byrne Stephen
School of Pharmacy, Cavanagh Pharmacy Building College Road Cork, University College Cork, Cork, Ireland.
Department of Geriatric Medicine, Cork University Hospital, Cork, Ireland.
Age Ageing. 2016 Jan;45(1):115-20. doi: 10.1093/ageing/afv166. Epub 2015 Dec 18.
potentially inappropriate prescribing (PIP) is a significant problem in health care today. We hypothesise that if doctors were given a single indicator of PIP and adverse drug reaction (ADR) risk on a patient's prescription, it might stimulate them to review the medicines. We suggest that a frailty index (FI) score may be such a suitable indicator.
to determine whether a positive relationship exists between a patient's frailty status, the appropriateness of their medications and their propensity to develop ADRs. Compare this to just using the number of medications a patient takes as an indicator of PIP/ADR risk.
a frailty index was constructed and applied to a patient database. The associations between a patient's FI score, the number of instances of PIP on their prescription and their likelihood of developing an ADR were determined using Pearson correlation tests and χ(2) tests.
significant correlation between FI score instances of PIP was shown (R = 0.92). The mean FI score above which patients experienced at least one instance of PIP was 0.16. Patients above this threshold were twice as likely to experience PIP (OR = 2.6, P < 0.0001) and twice as likely to develop an ADR (OR = 2.1, P < 0.0001). Patients taking more than six medications were 3 times more likely to experience PIP.
an FI score is a potentially relevant clinical indicator for doctors to critically assess a patient's prescription for the presence of PIP and ultimately prevent ADRs, especially when used in tandem with the number of medications a patient takes.
潜在不适当处方(PIP)是当今医疗保健中的一个重大问题。我们假设,如果在患者的处方上为医生提供一个PIP和药物不良反应(ADR)风险的单一指标,可能会促使他们审查用药情况。我们认为衰弱指数(FI)得分可能是这样一个合适的指标。
确定患者的衰弱状态、用药的适当性与其发生ADR的倾向之间是否存在正相关关系。将此与仅使用患者服用药物的数量作为PIP/ADR风险指标进行比较。
构建衰弱指数并将其应用于患者数据库。使用Pearson相关检验和χ²检验确定患者的FI得分、处方上PIP的实例数量与其发生ADR的可能性之间的关联。
显示FI得分与PIP实例之间存在显著相关性(R = 0.92)。患者经历至少一次PIP的平均FI得分是0.16。高于此阈值的患者发生PIP的可能性是两倍(OR = 2.6,P < 0.0001),发生ADR的可能性也是两倍(OR = 2.1,P < 0.0001)。服用六种以上药物的患者发生PIP的可能性高3倍。
FI得分是医生批判性评估患者处方中是否存在PIP并最终预防ADR的一个潜在相关临床指标,特别是当与患者服用药物的数量一起使用时。